| [1] |
Watson MA, Dintzis S, Darrow CM, et al. Mammaglobin expression in primary,metastatic, and occult breast cancer [J].Cancer Res,1999,59 (13):3028-3031.
|
| [2] |
Tanaka K, Shoji T, Tominaga Y, et al. Statistical analysis of diagnostic failure of fine needle aspiration cytology (FNAC)in breast cancer [J]. J Surg Oncol,2001,76(2):100-105.
|
| [3] |
Rita N, Cecilia B, Pellegrino C,et al. Immunocytochemical evaluation of HER-2/neu on fine-needle aspirates from primary breast carcinomas [J]. Diagn Cytopathol,2003,28(3):142-146.
|
| [4] |
Robinsin IA, McKee G, Nicholson A, et al. Prognostic value of cytological grading of fine-needle aspirates from breast carcinomas [J]. Lancet,1994,343(8903):947-949.
|
| [5] |
Taniguchi E, Yang Q, Tang W, et al. Cytologic grading of invasive breast carcinoma: correlation with clinicopathologic variables and predictive value of nodal metastasis [J]. Acta Cytol,2000,44(4):587 -591.
|
| [6] |
《乳腺癌HER2 检测指南》编写组.乳腺癌HER2 检测指南[J].中华病理学杂志,2006,35(10):631-633.
|
| [7] |
Watson MA, Fleming TP. Mammaglobin, a mammary specific member of the uteroglobin gene family is overexpressed in human breast cancer [J]. Cancer Res,1996,56 (4):860-865.
|
| [8] |
O'Brien N,Maguire TM, O'Donovan N, et al. Mammaglobin A: a promising marker for breast cancer [J]. Clin Chem,2002,48 ( 8):1362-1364.
|
| [9] |
Fritzsche FR, ThomasA,Winzer KJ, et al. Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer [J]. Histol Histopathol,2007,22(11):1221-1230.
|
| [10] |
Ariga R, Bloom K, Reddy VB, et al. Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation [J]. Am J Surg,2002,184(5):410-413.
|
| [11] |
Sneige N. Utility of cytologic specimens in the evaluation of prognostic and predictive factors of breast cancer: current issues and future directions [J]. Diagn Cytopathol,2004,30(3):158-165.
|
| [12] |
Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumors [J]. Nature,2000,406(17):747-752.
|
| [13] |
Liu H, Fan Q, Zhang Z, et al. Basal-HER-2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers [J]. Hum Pathol,2008,39(2):167 -174.
|
| [14] |
Guan XF, Hamedani MK, Adeyinka A, et al. Relationship between mammaglobin expression and estrogen receptor status in breast tumors [J]. Endocrine,2003,21(3):245-250.
|
| [15] |
Pan PN, Waanders E, Manders P, et al. Mammaglobin is associated with low-grade, steroid receptor positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time [J]. J Clin Oncol,2004,22 (4):691-698.
|
| [16] |
Houghton RL, DillonDC, Molesh DA, et al. Transcriptional complementarity in breast cancer: application to detection of circulating tumor cells [J]. Mol Diagn,2001,6 (2):79 -91.
|
| [17] |
Zafrakas M, Petschke B, Donner A, et al. Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B(SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies [J]. BMC Cancer,2006,6:88.
|
| [18] |
Sjodin A, Guo D, Hofer PA, et al. Mammaglobin in normal human sweat glands and human sweat gland tumors [J]. J Invest Dermatol,2003,121 (2):428 -429.
|